| KALV Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the KALV market cap history going back to 2/28/2017:
Also see: KALV Shares Outstanding History and KALV YTD Return |
KALV Market Cap History — KalVista Pharmaceuticals Capitalization Over Time
As of 5/7/2026 KalVista Pharmaceuticals has a market cap of 1.42 billion. Investors often follow the KALV market cap history to compare the size of the company over time.
This page shows KALV market capitalization trends over time, with 37 market cap datapoints presented, dating back to 2/28/2017.
| KALV Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
KALV Historical Market Cap: +38.53% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KALV Stock Price Chart |
| About KalVista Pharmaceuticals Inc |
| KalVista Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. Co. is focused on the discovery, development and commercialization of drug therapies for diseases with significant unmet need. Its product candidate is sebetralstat, an inhibitor of plasma kallikrein being developed for hereditary angioedema (HAE). Sebetralstat is designed to offer people living with HAE a medication that can be taken as a discreet oral dose to readily treat HAE attacks on-demand, including at the earliest signs before the attack fully develops. We show 37 historical shares outstanding datapoints in our KALV shares outstanding history coverage, used to compute KALV market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing KALV market cap history over the course of time is important for investors interested in comparing KALV's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of KALV versus a peer is one thing; comparing KALV market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like KALV can fluctuate over the course of history. With this page we aim to empower investors researching KALV by allowing them to research the KALV market cap history. |
| KALV Current Stock Quote |
Quotes delayed 20 minutes  Free KALV Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| KALV Share Performance |
| Market Cap Peers |
| KalVista Pharmaceuticals (KALV) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
KDMN Market Cap History KDNY Market Cap History KEQU Market Cap History KERX Market Cap History KIDS Market Cap History KIN Market Cap History KLDO Market Cap History KLRS Market Cap History KMPH Market Cap History KND Market Cap History More Healthcare companies » |
KALV Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
